Biological Variation Data in Triathletes for Metabolism and Growth-Related Biomarkers Included in the Athlete Biological Passport
Clinical Chemistry · 2024
DOI: 10.1093/clinchem/hvae072 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Chemistry, 2024. Verfasst von Isabel Moreno-Parro und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, La Paz University Hospital, Madrid, Spain. Hauptthemen laut MEDLINE: Insulin-Like Growth Factor I, Biomarkers, Insulin-Like Growth Factor Binding Protein 3, Athletes. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 34 Literaturangaben.
Abstract (Originalsprache)
Background
When using biological variation (BV) data, BV estimates need to be robust and representative. High-endurance athletes represent a population under special physiological conditions, which could influence BV estimates. Our study aimed to estimate BV in athletes for metabolism and growth-related biomarkers involved in the Athlete Biological Passport (ABP), by 2 different statistical models.
Methods
Thirty triathletes were sampled monthly for 11 months. The samples were analyzed for human growth hormone (hGH), insulin-like growth factor-1 (IGF-1), insulin-like growth factor binding protein 3 (IGFBP-3), insulin, and N-terminal propeptide of type III procollagen (P-III-NP) by immunoassay. Bayesian and ANOVA methods were applied to estimate within-subject (CVI) and between-subject BV.
Results
CVI estimates ranged from 7.8% for IGFBP-3 to 27.0% for insulin, when derived by the Bayesian method. The 2 models gave similar results, except for P-III-NP. Data were heterogeneously distributed for P-III-NP for the overall population and in females for IGF-1 and IGFBP-3. BV components were not estimated for hGH due to lack of steady state. The index of individuality was below 0.6 for all measurands, except for insulin.
Conclusions
In an athlete population, to apply a common CVI for insulin would be appropriate, but for IGF-1 and IGFBP-3 gender-specific estimates should be applied. P-III-NP data were heterogeneously distributed and using a mean CVI may not be representative for the population. The high degree of individuality for IGF-1, IGFBP-3, and P-III-NP makes them good candidates to be interpreted through reference change values and the ABP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, La Paz University Hospital, Madrid, Spain.
- IdiPaz-Hospital La Paz Institute for Health Research, Madrid, Spain.
- Department of Medical Biochemistry and Pharmacology, Haukeland University Hospital, Bergen, Norway.
- Norwegian Organization for Quality Improvement of Laboratory Examinations (Noklus), Haraldsplass Deaconess Hospital, Bergen, Norway.
- Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.
- World Anti-Doping Agency (WADA), Montreal, Quebec, Canada.
ORCID-Profile: Jorge Diaz-Garzon, Aasne K Aarsand, Reid Aikin
Zitieren
APA
Moreno-Parro, I., Diaz-Garzon, J., Aarsand, A. K., Sandberg, S., Aikin, R., Equey, T., Ríos-Blanco, J. J., Buño Soto, A., & Fernandez-Calle, P. (2024). Biological Variation Data in Triathletes for Metabolism and Growth-Related Biomarkers Included in the Athlete Biological Passport. Clinical Chemistry. https://doi.org/10.1093/clinchem/hvae072
Vancouver
Moreno-Parro I, Diaz-Garzon J, Aarsand AK, Sandberg S, Aikin R, Equey T, et al. Biological Variation Data in Triathletes for Metabolism and Growth-Related Biomarkers Included in the Athlete Biological Passport. Clinical Chemistry. 2024. doi:10.1093/clinchem/hvae072
BibTeX
@article{MorenoParro2024,
author = {Moreno-Parro, Isabel and Diaz-Garzon, Jorge and Aarsand, Aasne K and Sandberg, Sverre and Aikin, Reid and Equey, Tristan and Ríos-Blanco, Juan José and Buño Soto, Antonio and Fernandez-Calle, Pilar},
title = {Biological Variation Data in Triathletes for Metabolism and Growth-Related Biomarkers Included in the Athlete Biological Passport},
journal = {Clinical Chemistry},
year = {2024},
doi = {10.1093/clinchem/hvae072}
}
EUVIMED